Table 6.
Adiponectin (µg/mL) | ||||
---|---|---|---|---|
HV (N = 65) |
MS (N = 65) |
|||
Variable (mg/dL) | r | p | r | p |
HDL-C | 0.53 | <0.0001 | 0.32 | 0.0099 |
HDL1-C | 0.58 | <0.0001 | 0.27 | 0.0304 |
HDL2-C | 0.57 | <0.0001 | 0.38 | 0.0018 |
HDL3-C | 0.40 | 0.0009 | 0.34 | 0.0057 |
HDL4-C | −0.15 | 0.2239 | 0.13 | 0.3129 |
HDL-FC | 0.55 | <0.0001 | 0.42 | 0.0005 |
HDL1-FC | 0.52 | <0.0001 | 0.32 | 0.0087 |
HDL2-FC | 0.47 | 0.0001 | 0.33 | 0.0065 |
HDL3-FC | 0.20 | 0.1123 | 0.37 | 0.0027 |
HDL4-FC | −0.14 | 0.2639 | 0.26 | 0.0385 |
HDL-TG | 0.16 | 0.1958 | 0.24 | 0.0508 |
HDL1-TG | 0.44 | 0.0002 | 0.30 | 0.0136 |
HDL2-TG | 0.18 | 0.1434 | 0.23 | 0.0685 |
HDL3-TG | −0.09 | 0.4864 | 0.10 | 0.4067 |
HDL4-TG | −0.42 | 0.0005 | 0.00 | 0.9834 |
HDL-PL | 0.59 | <0.0001 | 0.43 | 0.0004 |
HDL1-PL | 0.61 | <0.0001 | 0.35 | 0.0042 |
HDL2-PL | 0.59 | <0.0001 | 0.40 | 0.0011 |
HDL3-PL | 0.42 | 0.0004 | 0.36 | 0.0030 |
HDL4-PL | −0.11 | 0.3640 | 0.20 | 0.1132 |
HDL-apoA-I | 0.49 | <0.0001 | 0.37 | 0.0022 |
HDL1-apoA-I | 0.58 | <0.0001 | 0.33 | 0.0082 |
HDL2-apoA-I | 0.54 | <0.0001 | 0.31 | 0.0110 |
HDL3-apoA-I | 0.38 | 0.0021 | 0.32 | 0.0084 |
HDL4-apoA-I | −0.22 | 0.0760 | 0.19 | 0.1328 |
HDL-apoA-II | −0.06 | 0.6577 | 0.12 | 0.3386 |
HDL1-apoA-II | 0.46 | 0.0001 | 0.20 | 0.1069 |
HDL2-apoA-II | 0.36 | 0.0031 | 0.14 | 0.2698 |
HDL3-apoA-II | −0.08 | 0.5036 | 0.13 | 0.2986 |
HDL4-apoA-II | −0.37 | 0.0027 | 0.00 | 0.9822 |
Spearman’s correlation analyses were used to evaluate the associations between the serum levels of adiponectin and the serum levels of the HDL subclasses. p-values < 0.0005 are considered statistically significant after Bonferroni correction for multiple testing and are depicted in bold. ApoA-I, apolipoprotein A-I; apoA-II, apolipoprotein A-II; C, cholesterol; FC, free cholesterol; HV, healthy volunteer; HDL, high-density lipoprotein; MS, metabolic syndrome patient; PL, phospholipid; r, Spearman’s correlation coefficient; TG, triglyceride.